The net valuation of total demand for pharmaceutical cold chain packaging requirements is likely to be around USD 15,176.2 million in 2023. Further, as per the pharmaceutical cold chain packaging market analysis report, it could progress at a higher compound annual growth rate of 14.8% through 2033. Consequently, the overall valuation of the market is projected to reach USD 60,100.9 million by the end of this forecast period.
The need for pharmaceutical cold chain packaging facilities has expanded recently due to the introduction of more complicated biologically based medications. Furthermore, increased shipments of vaccinations, hormone therapies, and intricate proteins that need cold chain packaging to be traded at a regulated temperature have also rendered the business rewarding.
Get the Complete Story—Read More About Our Latest Report!
Key Takeaways
- The United States pharmaceutical cold chain packaging market generated a revenue of around USD 2,494.5 million in the year 2022. This revenue share was around 18.6% of the global revenue making the United States the top region for the market.
- In Europe, Germany is the leading provider of pharmaceutical cold chain packaging services and contributes 3.8% to the global market share.
- In the Asia Pacific region, China tops in sales of pharmaceutical cold chain packaging services and other requirements for both domestic and adjacent markets. The net valuation of this regional market in 2022 was USD 1,503.7 million and it is also progressing at a 17.7% growth rate.
Prominent Drivers of the Pharmaceutical Cold Chain Packaging Market
- Increasing Demand for Temperature-Sensitive Medications: With the growing prevalence of biologics, vaccines, and other temperature-sensitive drugs, there is a rising demand for cold chain packaging solutions to maintain product integrity and efficacy during transport.
- Global Expansion of Vaccination Programs: The expansion of global vaccination initiatives, especially post-pandemic, has led to higher requirements for cold chain packaging to ensure the safe transportation of vaccines under precise temperature controls.
- Advancements in Packaging Technologies: Innovations such as smart packaging, temperature monitoring systems, and eco-friendly materials are improving the reliability and sustainability of cold chain packaging, driving market growth.
- Rising Regulatory Compliance Requirements: Stringent regulations and guidelines from global health authorities like the FDA, EMA, and WHO are pushing pharmaceutical companies to adopt secure and efficient cold chain solutions to comply with safety and quality standards.
- Growth of E-Commerce in Pharmaceutical Distribution: The rise of direct-to-consumer pharmaceutical sales through e-commerce platforms has increased the need for robust cold chain packaging to ensure that sensitive products reach customers in optimal condition.
Competitive Landscape
To lower package costs and increase market share, leading players in the pharmaceutical cold chain packaging market are investing in sophisticated technologies, forming alliances, and developing new products.
- Sonoco Thermosafe announced in August 2021 a cooperation with Korean Air, a well-known South Korean airline and carrier, to lease the newest shipping container temperature-controlled Pegasus ULD.
- In February 2021, Pelican Products began supplying temperature-controlled cases for COVID-19 vaccination delivery.
Key Players
Sonoco ThermoSafe; Cold Chain Technologies; Sealed Air Corporation; Nordic Cold Chain Solutions; Cryopak; CSafe Global LLC; TemperPack Technologies, Inc.; Insulated Product Corp.; Global Cooling, Inc.; Envirotainer AB; va-Q-tec AG; EMBALL’ISO; Softbox Systems; Sofrigam SAS; DGP Intelsius LLC; Tempack Packaging Solutions SL; TOWER Cold Chain Solutions; Pelican BioThermal LLC; Blue Star Limited; BIOBASE Group; Andores New Energy Co., Ltd.; Haier Biomedical Co. Ltd.; Tamai Kasei Co., Ltd.; Dhruvraj Syndicate; Valor Industries; KODIAKOOLER; WoolCool Ltd.; Allwin Roto Plast
Pharmaceutical Cold Chain Packaging Market by Category
By Packaging Format:
- Passive Packaging
- Single-use or One-way Use Packaging
- Multiple Use or Reusable Packaging
- Active Packaging
- Reefer Trucks and Containers
- Active Pallet Containers
By Product:
- Small Boxes
- Pallets
- Single Pallets
- Double Pallets
- Large Sized Pallet Containers
By Material:
- Polymer
- Polyethylene
- Polypropylene
- PET
- EPS
- Polyurethane
- Others
- Metal
- Paper
By Application:
- Biologics and Biological Samples
- Vaccines and Diagnostics
- Others
By End Use:
- Diagnostic Centers
- Clinical Research Organization
- Blood Banks
- Vaccines Packaging Industry
- Pharmaceuticals
- Other Healthcare Units
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube